03681.HK
SinoMab BioScience Limited
HKSE · Healthcare · Biotechnology · HK
HKD 1.15
+0.88%Aug 19, 2026, 01:12 UTC
China Antibody-B announced that Liang Fang resigned as executive director and chief operating officer, effective August 18, 2026, to devote more time to personal affairs.
Source: